This article was written by Follow Yiannis Zourmpanos, founder of Yiazou IQ, an AI-driven stock research platform providing all-in-one stock reports. Experience: Previously worked...
This article was written by Follow Samuel Smith has a diverse background that includes being lead analyst and Vice President at several highly regarded...
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish...
Over the past few months, I have reviewed several funds from Simplify Asset Management. Some have been hits like the Simplify Volatility Premium ETF...
US This week will deliver a make-or-break moment for Fed rate hike expectations. The main event will be the September inflation report. Expectations are...
Topline Summary Nurix Therapeutics (NASDAQ:NRIX) is a biotech company specializing in the development of protein degraders, which are intended as a new class of...
The most recent U.S. jobs data suggests the employment sector may be showing signs of cooling. Rannella Billy-Ochieng’, Senior Economist at TD, speaks with...
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) is a good speculative biotech play to look into. That’s because it expects to present preliminary results from an...
The Direxion Daily Technology Bear 3X Shares (NYSEARCA:TECS) is a leveraged ETF that takes a bear position against technology stocks that lead the market...
The American dream of homeownership has historically been symbolic of financial success. But for millennials burdened by student loan debt, it feels more elusive...